Pinnacle Financial Partners Inc Has $3.02 Million Holdings in Aflac Incorporated (NYSE:AFL)

Pinnacle Financial Partners Inc increased its position in shares of Aflac Incorporated (NYSE:AFL) by 1.4% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 27,593 shares of the financial services provider’s stock after buying an additional 390 shares during the period. Pinnacle Financial Partners Inc’s holdings in Aflac were worth $3,022,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Golden State Wealth Management LLC boosted its holdings in shares of Aflac by 121.9% during the 1st quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider’s stock worth $34,000 after buying an additional 167 shares in the last quarter. Curio Wealth LLC bought a new position in Aflac during the fourth quarter worth $36,000. Garde Capital Inc. acquired a new stake in Aflac in the first quarter worth $36,000. OFI Invest Asset Management bought a new stake in Aflac in the fourth quarter valued at $38,000. Finally, Capital A Wealth Management LLC acquired a new position in shares of Aflac during the fourth quarter valued at about $38,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Insider Buying and Selling

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total value of $106,790.00. Following the transaction, the director owned 26,096 shares of the company’s stock, valued at approximately $2,786,791.84. The trade was a 3.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Masatoshi Koide sold 37,000 shares of the firm’s stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the sale, the director directly owned 70,992 shares of the company’s stock, valued at approximately $7,496,045.28. This represents a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 40,750 shares of company stock worth $4,304,295. 0.90% of the stock is owned by company insiders.

Aflac Stock Performance

NYSE AFL opened at $103.51 on Thursday. The company has a fifty day moving average price of $104.41 and a 200-day moving average price of $105.21. The firm has a market cap of $55.96 billion, a price-to-earnings ratio of 16.17, a PEG ratio of 3.27 and a beta of 0.81. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09. Aflac Incorporated has a 1 year low of $88.00 and a 1 year high of $115.50.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.67 by ($0.01). The firm had revenue of $3.40 billion during the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a return on equity of 15.55% and a net margin of 21.27%. The company’s revenue for the quarter was down 37.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.66 earnings per share. As a group, equities research analysts predict that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were given a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date was Wednesday, May 21st. Aflac’s payout ratio is 36.25%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. JPMorgan Chase & Co. raised their target price on Aflac from $94.00 to $96.00 and gave the company a “neutral” rating in a research note on Wednesday, April 2nd. Raymond James Financial reduced their price objective on Aflac from $115.00 to $110.00 and set an “outperform” rating for the company in a research note on Thursday, May 29th. Wall Street Zen lowered Aflac from a “hold” rating to a “sell” rating in a research report on Monday, May 5th. Barclays lifted their price target on shares of Aflac from $95.00 to $96.00 and gave the company an “underweight” rating in a research report on Thursday, May 1st. Finally, UBS Group boosted their price target on shares of Aflac from $109.00 to $114.00 and gave the company a “neutral” rating in a research note on Wednesday, April 2nd. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $106.50.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.